2009•Journal of Dermatological TreatmentRequires access

A case of imiquimod-induced alopecia

Jennifer Conde, Katherine E. Davis, Edidiong Ntuen, Nicole Balmer, Daniel C. Jones, Amy McMichael

Abstract

Imiquimod cream 5% is an immune modifier approved for the treatment of genital warts, actinic keratosis, and basal cell carcinoma. This case report presents an isolated case of telogen effluvium after 6 weeks of imiquimod treatment for an actinic keratosis on the scalp. Based on this case presentation, telogen effluvium is a potential rare side effect from imiquimod treatment.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Imiquimod, Medicine, Dermatology, Actinic keratosis, Basal cell carcinoma, Keratosis, Genital warts, Scalp